AMD trades at a steeper valuation despite slower profit margins, while Arista's high customer concentration adds risk to its ...

Opko Health (OPK +33.06%) was one of the healthier stocks on the exchange Tuesday. Its price zoomed more than 33% higher, on the back of a very well-received quarterly earnings re ...

The rocket maker's public-market debut gets its first report card in a week. Three things will decide how it goes.

Nvidia (NVDA +0.42%) hasn't been the workhorse stock it normally is in 2026. This year, it has risen around 11%, just barely ...

ExxonMobil reported its first-quarter financial results in early May. The oil giant delivered mixed results. While it beat analysts' expectations ($1.16 per share of adjusted earnings compared to the ...

Martine Rothblatt exercised options at $135.42 and sold at $530.42 under a pre-established Rule 10b5-1 plan, reducing her ...

These solid results prompted Coca-Cola to lift its full-year outlook. Management now projects organic revenue growth of ...

Shares of Viking Therapeutics (VKTX-2.90%), a clinical-stage biotech, have declined by 46% over the past two years. There are several reasons for this. First, longtime shareholder ...

The state of Intel stock. Admittedly, Intel stock was arguably undervalued one year ago. Years of underperformance led it to lose its long-held title of the "world's largest semic ...

Even better, Power adds that Palantir is on track to generate potentially as much as $8 billion in positive free cash flow-- although for now, he's forecasting only a more conservative $6.7 billion.

That morning, Itron revealed that revenue for the period fell 7% year over year to $563 million. The company's bottom line ...

Apple has posted strong financial results over the past few quarters. The company has returned to double-digit year-over-year ...